+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Joint Pain Injections Market by Injection Type (Corticosteroid Injections, Hyaluronic Acid Injections), Joint Type (Facet Joints of the Spine, Hip Joint, Knee & Ankle), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4905012
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Joint Pain Injections Market size was estimated at USD 4.55 billion in 2023, USD 5.04 billion in 2024, and is expected to grow at a CAGR of 10.94% to reach USD 9.42 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Joint Pain Injections Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Joint Pain Injections Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Joint Pain Injections Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., Asterisk Laboratories (I) Pvt. Ltd., Bioventus LLC, Chugai Pharmaceutical Co., Ltd., Ferring B.V., Henry Schein, Inc., Hetero Healthcare Limited, Krosyl Pharmaceuticals Pvt. Ltd., Medilink Pharma, Pfizer Inc., Salavidas Pharmaceutical Pvt. Ltd., Sanofi S.A., Seikagaku Corporation, TEENA LABS LTD, Wellona Pharma, and Zimmer Biomet Holdings, Inc.

Market Segmentation & Coverage

This research report categorizes the Joint Pain Injections Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Injection Type
    • Corticosteroid Injections
    • Hyaluronic Acid Injections
  • Joint Type
    • Facet Joints of the Spine
    • Hip Joint
    • Knee & Ankle
    • Shoulder & Elbow
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Joint Pain Injections Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Joint Pain Injections Market?
  3. What are the technology trends and regulatory frameworks in the Joint Pain Injections Market?
  4. What is the market share of the leading vendors in the Joint Pain Injections Market?
  5. Which modes and strategic moves are suitable for entering the Joint Pain Injections Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Joint Pain Injections Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of joint disorders across globe
5.1.1.2. Rising cases of rheumatoid arthritis, osteoarthritis, spinal disorders, and severe limb trauma
5.1.1.3. Availability of awareness programs by government organizations
5.1.2. Restraints
5.1.2.1. High cost of the joint pain injections
5.1.3. Opportunities
5.1.3.1. Advancement in osteoarthritis pain treatment
5.1.3.2. Growing awareness about benefits of intra-articular injections
5.1.4. Challenges
5.1.4.1. Lack of awareness regarding injections
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Joint Pain Injections Market, by Injection Type
6.1. Introduction
6.2. Corticosteroid Injections
6.3. Hyaluronic Acid Injections
7. Joint Pain Injections Market, by Joint Type
7.1. Introduction
7.2. Facet Joints of the Spine
7.3. Hip Joint
7.4. Knee & Ankle
7.5. Shoulder & Elbow
8. Joint Pain Injections Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Americas Joint Pain Injections Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Joint Pain Injections Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Joint Pain Injections Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Anika Therapeutics, Inc.
13.1.2. Asterisk Laboratories (I) Pvt. Ltd.
13.1.3. Bioventus LLC
13.1.4. Chugai Pharmaceutical Co., Ltd.
13.1.5. Ferring B.V.
13.1.6. Henry Schein, Inc.
13.1.7. Hetero Healthcare Limited
13.1.8. Krosyl Pharmaceuticals Pvt. Ltd.
13.1.9. Medilink Pharma
13.1.10. Pfizer Inc.
13.1.11. Salavidas Pharmaceutical Pvt. Ltd.
13.1.12. Sanofi S.A.
13.1.13. Seikagaku Corporation
13.1.14. TEENA LABS LTD
13.1.15. Wellona Pharma
13.1.16. Zimmer Biomet Holdings, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. JOINT PAIN INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. JOINT PAIN INJECTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. JOINT PAIN INJECTIONS MARKET DYNAMICS
FIGURE 7. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2030 (%)
FIGURE 8. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2030 (%)
FIGURE 10. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. JOINT PAIN INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. JOINT PAIN INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL JOINT PAIN INJECTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 6. JOINT PAIN INJECTIONS MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. JOINT PAIN INJECTIONS MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 9. JOINT PAIN INJECTIONS MARKET SIZE, BY FACET JOINTS OF THE SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. JOINT PAIN INJECTIONS MARKET SIZE, BY HIP JOINT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. JOINT PAIN INJECTIONS MARKET SIZE, BY KNEE & ANKLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. JOINT PAIN INJECTIONS MARKET SIZE, BY SHOULDER & ELBOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. JOINT PAIN INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. JOINT PAIN INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. JOINT PAIN INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES JOINT PAIN INJECTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY INJECTION TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY JOINT TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM JOINT PAIN INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. JOINT PAIN INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. JOINT PAIN INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. JOINT PAIN INJECTIONS MARKET LICENSE & PRICING

Companies Mentioned

  • Anika Therapeutics, Inc.
  • Asterisk Laboratories (I) Pvt. Ltd.
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Ferring B.V.
  • Henry Schein, Inc.
  • Hetero Healthcare Limited
  • Krosyl Pharmaceuticals Pvt. Ltd.
  • Medilink Pharma
  • Pfizer Inc.
  • Salavidas Pharmaceutical Pvt. Ltd.
  • Sanofi S.A.
  • Seikagaku Corporation
  • TEENA LABS LTD
  • Wellona Pharma
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information